Michael J. Palumbo
Allergy and Immunology
180 Fort Couch Road, Suite 375
Pittsburgh, PA 15241
Pittsburgh, PA 15241
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: February 02, 2026
Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies.
Journal: The Journal of allergy and clinical immunology
Published: June 16, 2025
A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: January 08, 2025
Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump.
Journal: Immunotherapy
Published: September 21, 2022
Showing 1-4 of 4
Last Updated: 09/26/2026